Touchlight welcomes Dr. Geoff Smith
- Posted on 19 May, 2017
Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.
Geoff is a world expert in genomics technologies and their applications. He spent more than 10 years working at Solexa/Illumina, where he led the invention of many aspects of the core SBS sequencing chemistry, workflows and platforms, becoming Vice President leading Technology Development globally and clinical product development for cell-free DNA testing in pregnancy (NIPT). After leaving Illumina, Geoff was CEO of Cambridge Epigenetix, a spin-out from Cambridge University, and now works closely with a number of biotech companies in the genomics space.
Share this article:
People also read
SynbiTECH 2020 - Register your interest
SynbiTECH will return to London on 6-7th July 2020!To be kept up to date on ticket sales and conference announcements please register your interest he...
Prokarium secures £4.6m Wellcome funding for Entervax
Prokarium has announced an investment of £4.59 million from Wellcome to fund two clinical trials of its lead programme, Entervax.Follow this link for ...
Book before March 29th to receive 20% discount*
Building a multibillion-dollar synthetic biology industry The Synthetic Biology conference taking place in 2019, in London, that is not to be missed....